Patient Access & Affordability
  • About
    • Mission
    • Who We Are
    • Professional Advisory Council
    • Patient Advisors
    • Members
    • Funding
    • Contact
  • Resources
    • Blog
    • Watch & Listen
    • Surveys
  • Publications
    • Research Briefings
    • Current Issues
    • Fast Facts
    • Policy Platform
  • Working Groups
    • Benefit Design
    • Rare Disease Health Technology Assessment
      • Featured Work
    • Biosimilars & Complex Generics
  • ICERWATCH
    • What is ICER?
    • ICER Glossary
    • Analysis and Commentary
    • Public Comments
Select Page
Peanut allergies are terrifying. ICER wants to block new treatments to boost insurance profits.

Peanut allergies are terrifying. ICER wants to block new treatments to boost insurance profits.

Jul 18, 2019

Any parent of a child can tell you: there’s nothing more frightening than an allergy attack. One in 10 Americans live with a food allergy. Peanut allergies are not only one of the most common food allergies, but it’s also one of the most severe. Even the slightest...

Categories

  • Access & Affordability
  • Blog
  • Comments
  • ICERWatch
  • News
  • Opinion
  • QALY
  • Research
  • Resources
  • Statements
  • Uncategorized
  • Video

IPAA

700 12th St. NW, Suite 700
Washington, DC 20005
202-750-1186 |  info@accessandaffordability.org

The Patient Access & Affordability Project is a program of Patients Rising, a national 501(c)3 nonprofit organization, and is governed by the Patients Rising Board of Directors.

  • Facebook
  • Twitter
  • RSS